- Home
- WST vs CBOE Comparison
WST vs CBOE Comparison
Compare WST & CBOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WST | CBOE |
|---|---|---|
| Founded | 1923 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.9B | 25.6B |
| IPO Year | 2004 | 2010 |
Fundamental Metrics
Financial Performance| Metric | WST | CBOE |
|---|---|---|
| Price | $367.06 | $266.67 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 9 |
| Target Price | ★ $325.86 | $289.44 |
| AVG Volume (30 Days) | 350.9K | ★ 965.5K |
| Earning Date | 04-23-2026 | 05-01-2026 |
| Dividend Yield | 0.30% | ★ 0.94% |
| EPS Growth | 1.49 | ★ 44.52 |
| EPS | 4.07 | ★ 7.01 |
| Revenue | ★ $2,886,900,000.00 | $2,229,100,000.00 |
| Revenue This Year | $6.76 | N/A |
| Revenue Next Year | $6.22 | $3.54 |
| P/E Ratio | $90.06 | ★ $38.04 |
| Revenue Growth | 1.95 | ★ 239.31 |
| 52 Week Low | $223.83 | $227.15 |
| 52 Week High | $386.00 | $371.18 |
Technical Indicators
Market Signals| Indicator | WST | CBOE |
|---|---|---|
| Relative Strength Index (RSI) | 66.30 | 33.89 |
| Support Level | $346.45 | $249.28 |
| Resistance Level | $367.66 | $305.98 |
| Average True Range (ATR) | 7.78 | 9.89 |
| MACD | 2.77 | -4.33 |
| Stochastic Oscillator | 87.18 | 0.04 |
Price Performance
Historical ComparisonAbout WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About CBOE Cboe Global Markets Inc.
Founded in 1973, Cboe controls the largest option exchange in the US, which provides around 60% of the firm's revenue. The company is best known for its proprietary S&P 500 and VIX index options, which it offers through an exclusive contract with S&P Global. The firm moved into US and European equities through the $3.4 billion acquisition of BATS in 2017. Cboe has continued to look to expand internationally, using acquisitions to build a presence in both Canada and Australia.